MAT Waivered Prescriber Support Initiative Presents: Medications for Opioid Use Disorder

Wednesday, June 24, 2020, 12:00 AM - Thursday, September 29, 2022, 12:00 AM PST

Internet Enduring Material Sponsored by Stanford University School of Medicine. Presented by the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. 

The purpose of this online training is to provide participants with a detailed overview of medications that have been shown to be effective as a component of the treatment of opioid use disorder. Topics will include: the context for medication-assisted treatment (positive and negative perceptions), the epidemiology of opioid use and dependence (user demographics), a review of the various classes of opioids, an overview of each medication, its indication, to whom it is administered, and how it works, and treatment settings for medication-assisted treatment. Medications will include: naltrexone, methadone, and buprenorphine.

  Release Date: June 24, 2020
  Expiration Date: September 29, 2022
  Estimated Time to Complete: 30mins
  Registration Fee: FREE

AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Participation Credit (0.50 hours)

1. Specify the three (3) medications to treat opioid use disorders
2. Describe at least three (3) benefits for using medication assisted treatment.
3. Implement at least three (3) strategies to prevent opioid overdose.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Bibliography
Provider Resources: http://www.uclaisap.org/ca-hubandspoke/html/provider-resources.html
Factsheets and Toolkits: http://uclaisap.org/MATPrescriberSupport/html/factsheets-toolkits.html

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

For activity related questions, please contact
     Name: Laura Corbett
     Title: CME Compliance Coordinator
     Ph: (650)-736-9761
     Email: [email protected]

For CME general questions, please contact 
     Ph: (650)-497-8554
     Email: [email protected]

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.